Related Experiment Video
Updated: May 5, 2026

Characterization of Cell Membrane Extensions and Studying Their Roles in Cancer Cell Adhesion Dynamics
Published on: March 26, 2018
The adherens junction protein afadin is an AKT substrate that regulates breast cancer cell migration
Sivan Elloul1, Dmitriy Kedrin, Nicholas W Knoblauch
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115. atoker@bidmc.harvard.edu.
Unlabelled:
The PI3K-AKT signaling pathway regulates all phenotypes that contribute to progression of human cancers, including breast cancer. AKT mediates signal relay by phosphorylating numerous substrates, which are causally implicated in biologic responses such as cell growth, survival, metabolic reprogramming, migration, and invasion. Here a new AKT substrate is identified, the adherens junction protein Afadin, which is phosphorylated by AKT at Ser1718. Importantly, under conditions of physiologic IGF-1 signaling and oncogenic PI3K and AKT, Afadin is phosphorylated by all AKT isoforms, and this phosphorylation elicits a relocalization of Afadin from adherens junctions to the nucleus. Also, phosphorylation of Afadin increased breast cancer cell migration that was dependent on Ser1718 phosphorylation. Finally, nuclear localization of Afadin was observed in clinical breast cancer specimens, indicating that regulation of Afadin by the PI3K-AKT pathway has pathophysiologic significance.
Implications:
Phosphorylation of the adhesion protein Afadin by AKT downstream of the PI3K pathway, leads to redistribution of Afadin and controls cancer cell migration.
Insights
The PI3K-AKT pathway regulates cancer progression. AKT phosphorylates Afadin, causing it to move to the nucleus and increase breast cancer cell migration.
Area of Science:
- Oncology
- Cell Biology
- Molecular Signaling
Background:
- The PI3K-AKT pathway is crucial for human cancer progression, including breast cancer.
- AKT phosphorylates substrates involved in cell growth, survival, migration, and invasion.
Purpose of the Study:
- To identify new AKT substrates involved in cancer progression.
- To investigate the role of Afadin phosphorylation by AKT in breast cancer.
Main Methods:
- Identification of Afadin as a novel AKT substrate phosphorylated at Ser1718.
- Analysis of Afadin relocalization upon AKT activation under various signaling conditions.
- Assessment of Afadin phosphorylation's impact on breast cancer cell migration.
- Examination of Afadin nuclear localization in clinical breast cancer samples.
Main Results:
- Afadin is phosphorylated by AKT at Ser1718, leading to its nuclear relocalization.
- This phosphorylation event enhances breast cancer cell migration in a Ser1718-dependent manner.
- Nuclear localization of Afadin was confirmed in clinical breast cancer specimens.
Conclusions:
- Phosphorylation of Afadin by AKT, a key event in the PI3K-AKT pathway, drives breast cancer cell migration.
- The PI3K-AKT-Afadin axis represents a significant pathway in breast cancer pathophysiology.
Related Concept Videos
Adherens Junctions
Adherens Junctions are Dynamic
Intracellular Signaling Affects Focal Adhesions
Some...
Tension Response at Adherens Junctions
α-Catenin as a Mechanosensory Protein
The α-catenin of adherens junctions is an allosteric protein with three VH (vinculin...
Cancer Cell Migration through Invadopodia
Anchoring Junctions
Formation of Higher-order Actin Filaments
The high-order actin...

